Expression of transforming growth factor beta in oral submucous fibrosis
Background: Oral submucous fibrosis (OSMF) is a premalignant condition mainly caused by areca nut chewing and is characterized by progressive fibrosis of submucosal tissues and epithelial atrophy. Activation of transforming growth factor beta (TGF-β) signaling is considered main causative event for...
Saved in:
| Main Authors: | Arpita Rai, Tanveer Ahmad, Shama Parveen, Saba Parveen, Md Imam Faizan, Sher Ali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-04-01
|
| Series: | Journal of Oral Biology and Craniofacial Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2212426820300324 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An in-vitro exploration of the antifibrotic activity of Naringenin: A potential therapeutic agent for oral submucous fibrosis management
by: S. Samyuktha Aarthi, et al.
Published: (2025-07-01) -
Structural insights and clinical advances in small-molecule inhibitors targeting TGF-β receptor I
by: Carlota Leonardo-Sousa, et al.
Published: (2025-03-01) -
Osthole mitigates the myofibroblast properties in oral submucous fibrosis by suppressing the TGF-β/smad2 signaling pathway and NCK-AS1 expression
by: Po-Yu Yang, et al.
Published: (2025-04-01) -
Cystatin C: Its role in pathogenesis of OSMF
by: P.C. Anila Namboodiripad
Published: (2014-01-01) -
Inhibitory effect of melatonin on peritoneal fibrosis in rats and its mechanism
by: ZHAO Hua, et al.
Published: (2017-01-01)